Discontinued — last reported Q4 '25
Boston Scientific Latin Americaand Canada — Net Sales remained flat by 0.0% to $169.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.7%, from $156.00M to $169.50M. Over 4 years (FY 2021 to FY 2025), Latin Americaand Canada — Net Sales shows an upward trend with a 15.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful market penetration, effective distribution strategies, or rising demand for medical devices in these regions, while a decrease may signal competitive pressure, economic volatility, or regulatory challenges.
This metric represents the total revenue generated from the sale of medical devices and related services within the Lati...
Peers in the medical device industry typically report geographic revenue segments to highlight regional growth trends and exposure to emerging versus developed market dynamics.
bsx_segment_latin_america_and_canada_net_sales| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $386.00M | $469.00M | $560.00M | $624.00M | $678.00M |
| YoY Change | — | +21.5% | +19.4% | +11.4% | +8.7% |